Personal tools
Log in

Skip to content. | Skip to navigation

Sections
You are here: Home Library Health Topics Collection Guidelines Best evidence statement (BESt). Growth hormone therapy in Duchenne muscular dystrophy. Cincinnati Children's Hospital Medical Center. NGC:007487
Document Actions

Best evidence statement (BESt). Growth hormone therapy in Duchenne muscular dystrophy. Cincinnati Children's Hospital Medical Center. NGC:007487

Publication Details
Author(s):
  • AHRQ (US) - Agency for Healthcare Research and Quality
Country(ies) of application:
  • United States
Language(s):
  • English
Type of Publication:
Guideline Clearing Report
Primary Contact:
Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov
Publication URL:
Open Publication URL in a new window
Publication Scope:
  • Management
Publication Status:
Published
Date of publication:
Jul 20, 2009
Due for Review:
-
Diseases / Conditions Addressed
MeSH Terms addressed:
  • Musculoskeletal Diseases (C05)
    • Muscular Diseases (C05.651)
  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)
    • Genetic Diseases, Inborn (C16.320)
  • Neurological Disorders / Nervous System Diseases (C10)
    • Neuromuscular Diseases (C10.668)
  • Therapeutics (E02)
    • Drug Therapy (E02.319)
      • Hormone Replacement Therapy (E02.319.452)
  • Pediatrics (G02.403.776.610)
Guideline key questions
Page last updated: Sep 19, 2010

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.